Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
29.1x5.55x0.69x7.47x22.48x23.19x0.06% 49.39B
16.85x3.25x-1.96x5.11x11.17x12.87x1.77% 45.18B
-40.23x62.26x0.69x13.33x-36.59x-42.15x-.--% 23.28B
-17.54x1.03x2.15x3.03x-5.52x-4.35x-.--% 22.2B
21.67x2.13x1.53x4.28x11.11x13.38x-.--% 17.43B
22.46x2.52x-0.94x4.4x14.53x16.3x-.--% 15.79B
925.38x10.2x-8.52x16.47x95.9x207.27x-.--% 13.26B
-433.22x17.71x9.12x31.09x-1947.04x-306.03x-.--% 12.79B
15.41x4.36x1.13x4.42x10.35x11.4x-.--% 12.23B
-13.77x164.35x0.71x3565.87x-17.68x-13.82x-.--% 12.3B
-74.97x26.25x1.6x7.53x-71.04x-55.34x-.--% 11.8B
-23.17x23.81x-0x21x-26.95x-21.81x-.--% 10.31B
34.35x7.55x0.49x10.9x29.54x26.03x0.27% 9.33B
-9.29x - -0.08x - - - - 8.13B
28.87x4.72x-2.3x6.51x25.34x28.91x - 7.9B
11.75x5.79x0.03x7.17x12.01x12.69x-.--% 8.09B
-17.56x6.75x10.38x546.29x-15.24x-15.04x-.--% 7.98B
117.56x2.37x-2.06x4.7x23.34x50.94x0.12% 7.16B
-5.73x - -0.11x - -5.87x-5.4x-.--% 7.04B
-32.78x - -6.05x - - - - 6.39B
Average 27.76x 20.62x 0.33x 250.56x -103.90x -3.39x 0.13% 15.4B
Weighted average by Cap. 26.80x 18.11x 0.26x 176.56x -79.03x -0.52x 0.3%
Bio Therapeutic Drugs